CapsoVision, Inc
CapsoVision, Inc. (Nasdaq: CV) is a commercial-stage medical technology company that develops diagnostic and screening products for gastrointestinal (GI) tract abnormalities. Its capsule endoscopy system combines single-use CapsoCam capsules with CapsoCloud and CapsoView software: the capsules capture panoramic video… From the company’s description.
In fiscal 2025, CapsoVision, Inc reported revenue of $13.55M and a net loss of $25.32M. Its operating margin was −188.3%, and operations used $22.86M in cash. Over the twelve months to Jun 30, 2026, revenue was $13.89M.
Dotted labels explain each measure. is shown separately from the annual figures.
What CapsoVision, Inc does
In the company’s own words
CapsoVision, Inc. (Nasdaq: CV) is a commercial-stage medical technology company that develops diagnostic and screening products for gastrointestinal (GI) tract abnormalities. Its capsule endoscopy system combines single-use CapsoCam capsules with CapsoCloud and CapsoView software: the capsules capture panoramic video and store it onboard, while providers review the images through cloud streaming or downloaded data. Its marketed CapsoCam Plus is used to visualize the small bowel in adults and children aged two and above; customers are primarily gastroenterologists in clinics and hospitals. The company is also developing CapsoCam Colon, designed to visualize the colon and detect and measure polyps, and is advancing AI-assisted image analysis and related accessories. CapsoVision sells in the United States mainly through its in-house sales team and internationally through in-house sales and distributors. It reports one core business focused on GI-tract capsule endoscopy. In 2025, CapsoCam Plus sales generated approximately $13.6 million in revenue, and the product had been used in more than 161,000 patients as of year-end. Its website is www.capsovision.com.
Company details
- Sector
- Health Care
- Industry (SIC)
- Electromedical Apparatus
- Headquarters
- SARATOGA, CA
- Fiscal year end
- December
- CIK
- 1378325
- SIC
- 3845
Financial performance, year by year
Fiscal 2025–2025 · USDThe full income statement, balance sheet and cash flow for each of these years — every figure traceable to its filing — is on the Financials tab with a free account.
Who owns CapsoVision, Inc — and what changed
Funds as of 2026Q2 · superinvestors as of 2026-06-30
Largest fund holders · CapsoVision, Inc’s weight in each
Fund ownership is a floor, not a census — pensions, insurers and people holding shares directly are not visible here.
Fund ownership counts N-PORT filers only, so it is a floor rather than a census — pensions, insurers and direct holders are not visible here, and the remainder is not “held by individuals”.
Every fund and institutional holder, quarter by quarter, is on the Ownership tab with a free account.
Recent filings
All filings →Each filing opens into its own statements and disclosures here.
Put this business in context.
Compare this company with peers, find it in your funds and follow its financial history with your connected AI:
- “How do CapsoVision, Inc and its peers compare on margins and cash generation over ten years?”
- “Where did five years of CapsoVision, Inc's earnings go — cash, debt, buybacks, reinvestment?”
- “What changed in CapsoVision, Inc's last four quarterly filings that the numbers alone won't show?”